Oscar Health, Inc. (OSCR) Outperforms Broader Market: What You Need to Know

Company Performance - Oscar Health, Inc. (OSCR) closed at $19.28, reflecting a +2.01% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.06% [1] - The company's shares increased by 6.9% over the past month, surpassing the Finance sector's gain of 0.8% and the S&P 500's gain of 3.94% [1] Earnings Projections - Oscar Health, Inc. is expected to report earnings of -$0.55 per share, indicating a year-over-year decline of 150% [2] - Revenue is projected at $3.09 billion, representing a 27.51% increase from the prior-year quarter [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of -$1.42 per share and revenue of $12.06 billion, reflecting shifts of -1520% and +31.44% respectively from the last year [3] - Recent changes to analyst estimates may indicate a favorable outlook on the company's business health and profitability [3] Analyst Ratings - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently rates Oscar Health, Inc. at 4 (Sell) [5] - The consensus EPS projection has remained stagnant over the past 30 days [5] Industry Context - Oscar Health, Inc. operates within the Insurance - Multi line industry, which holds a Zacks Industry Rank of 82, placing it in the top 34% of over 250 industries [6] - The Zacks Industry Rank measures the strength of industry groups, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [6]